🇰🇷 South Korea Country × Condition
ovarian cancer Clinical Trials in South Korea
Active clinical trials for ovarian cancer with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇰🇷 South Korea
Active Trials in South Korea (3)
NCT05103683 Phase 1
Recruiting
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Enrollment
90 pts
Country
🇰🇷 South Korea
TORL Biotherapeutics, LLC
View Trial → NCT05912972
Recruiting
Development and Management of Registry in Patients With Gynecologic Cancer in Korea
Enrollment
13,500 pts
Country
🇰🇷 South Korea
Asan Medical Center
View Trial → NCT06695845 Phase 2
Recruiting
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Enrollment
200 pts
Country
🇰🇷 South Korea
Jazz Pharmaceuticals
View Trial → Frequently Asked Questions
How many ovarian cancer clinical trials are active in South Korea?
There are currently 3 active clinical trials for ovarian cancer with sites in South Korea, of which 3 are actively recruiting patients.
How can I join a ovarian cancer clinical trial in South Korea?
To join a ovarian cancer clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are ovarian cancer trials in South Korea?
Active ovarian cancer trials in South Korea span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology